The U.S. is on the brink of reclassifying marijuana as a Schedule III substance, acknowledging its medical benefits while reshaping the landscape for research, taxation, and public perception. Discover the implications of this pivotal change in our detailed analysis
Roadside Rebellion: Navigating Minnesota’s High Stakes Saliva Swabs
Minnesota's roads are watching. Know your rights and how to exercise them under the new saliva testing regime. Drive wise—refuse to be a test subject in the age of legal cannabis
Cannabis Countdown: DEA's Pot Power Play Could Blow the Lid Off Schedule I
As rumors swirl about a potential DEA announcement to reschedule cannabis, the implications for medical research and industry regulations could be transformative. Will the DEA's decision ignite a new era for cannabis in America? Stay tuned for a groundbreaking shift in drug policy dynamics.
Louisiana's Legislative Leap: Charting a New Course for Cannabis Reform
As Louisiana edges closer to a pivotal transformation in cannabis policy, House Bill 707 proposes not just to legalize adult-use cannabis, but to overhaul the state's regulatory framework. This measure lays the groundwork for a potential economic boom and enhanced safety regulations, setting the stage for a profound shift in 2024 and beyond
Why Cannabis Reigns Supreme in a World of Risk
In a world teetering on the edge of a pharmacological apocalypse, cannabis emerges not as a mere survivor but as a beacon of safety and sanity. This article delves into why cannabis, amidst the lethal shadows of substances like fentanyl and cocaine, claims the crown as the safest choice in the realm of recreational drugs
Paradise Lost: How Hawaii’s Fear of Freedom Crushed Cannabis Decriminalization Dreams
Hawaii’s Senate halts a progressive bill to decriminalize cannabis, citing public safety concerns and fears of bolstering the unregulated market